SCHEMBL16731518

SCHEMBL16731518

O=S(=O)(c1ccccc1)N(CCF)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 9/20 0.81
NR1H2 P55055 10/20 0.74
NR1I2 O75469 8/20 0.74
NR1H3 Q13133 7/20 0.74
RORA P35398 3/20 0.74
RORB Q92753 3/20 0.74
NR1H4 Q96RI1 3/20 0.74
ALDH1A1 P00352 1/20 0.74
MAPT P10636 1/20 0.74
RXRA P19793 1/20 0.74
SREBF1 P36956 1/20 0.74
PSEN1 P49768 1/20 0.74
PSEN2 P49810 1/20 0.74
NR1I3 Q14994 1/20 0.74
APH1B Q8WW43 1/20 0.74
NCSTN Q92542 1/20 0.74
APH1A Q96BI3 1/20 0.74
PSENEN Q9NZ42 1/20 0.74
HSD11B1 P28845 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013542 0.89 RORC (0.76) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL7016049 0.86 RORC (0.76) RORCNR1H2NR1I2NR1H3RORA
T091317 SCHEMBL457231 0.85 RORC (1.00) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL14732110 0.85 RORC (1.00) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL14732184 0.84 RORC (0.77) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL7022970 0.82 NR1H2 (0.71) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL16063605 0.79 RORC (0.86) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL2762946 0.78 NR1H3 (1.00) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL14300433 0.78 NR1H2 (0.71) RORCNR1H2NR1I2NR1H3RORA
SCHEMBL21115115 0.74 RORC (0.46) RORCNR1H2NR1I2NR1H3RORA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586928-B2 Modulators of the nuclear hormone receptor ROR THE SCRIPPS RESEARCH INSTITUTE (US) 2017-03-07 US disclosed
US-20160310454-A1 LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA D'ARMIENTO JEANINE (US) 2016-10-27 US disclosed
US-20150141390-A1 PLANT STEROIDS AND USES THEREOF DAVIDSON LOPEZ, LLC (US) 2015-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141390-A1 PLANT STEROIDS AND USES THEREOF CYP46A1, CYP17A1, NR1H4 RORC 65/4885NR1H2 27/4885NR1I2 124/4885
US-20160310454-A1 LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA TLR3, NR1H2, TLR4 RORC 180/4885NR1H2 2/4885NR1I2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.